摘要
The abnormal activation of epidermal growth factor receptor (EGFR) drives the development of non-small cell lung cancer (NSCLC). The EGFR-targeting tyrosine kinase inhibitor osimertinib is frequently used to clinically treat NSCLC and exhibits marked efficacy in patients with NSCLC who have an EGFR mutation. However, free osimertinib administration exhibits an inadequate response in vivo, with only similar to 3% patients demonstrating a complete clinical response. Consequently, we designed a biomimetic nanoparticle (CMNP@Osi) comprising a polymeric nanoparticle core and tumor cell-derived membrane-coated shell that combines membrane-mediated homologous and molecular targeting for targeted drug delivery, thereby supporting a dual-target strategy for enhancing osimertinib efficacy. After intravenous injection, CMNP@Osi accumulates at tumor sites and displays enhanced uptake into cancer cells based on homologous targeting. Osimertinib is subsequently released into the cytoplasm, where it suppresses the phosphorylation of upstream EGFR and the downstream AKT signaling pathway and inhibits the proliferation of NSCLC cells. Thus, this dual-targeting strategy using a biomimetic nanocarrier can enhance molecular-targeted drug delivery and improve clinical efficacy.
学科与关键词
- An Activatable Nano-Prodrug for Treating Tyrosine-Kinase-Inhibitor-Resistant Non-Small Cell Lung Cancer and for Optoacoustic and Fluorescent ImagingXie, Xin; Zhan, Chenyue; Wang, Jie; Zeng, Fang*; Wu, Shuizhu*Small, 2020, 16(38): 2003451.被引 22
- Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancerDiao, Dingwei; Zhai, Jianxue; Yang, Jianjun; Wu, Hua; Jiang, Jianjun; Dong, Xiaoying; Passaro, Antonio; Aramini, Beatrice; Rao, Shuan*; Cai, Kaican*Translational Lung Cancer Research, 2021, 10(2): 926-935.被引 5
- Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung CancerLiu, Meng; Sun, Chuanchuan; Jiang, Jiangle; Wan, Li; Hu, Chong; Wen, Chunping; Huang, Guiju; Ruan, Qiufen; Wu, Shuang; Qiao, Dan; Zheng, Pengwu; Pan, Qingshan*; Zhu, Wufu*ACS Applied Nano Materials, 2023, 6(23): 21587-21602.
